AngioDynamics (ANGO) Director Michael Tarnoff Receives RSU Award

What Happened

• Michael E. Tarnoff, a director of AngioDynamics, received 11,887 restricted stock units (RSUs) on July 15, 2026. The grant was reported as an Award/Grant (code A) at $0.00 per share (standard for RSU grants). The filing shows no cash paid — the RSUs were issued as compensation and immediately vested.

Key Details

• Transaction date: July 15, 2026; Filing date: July 22, 2026 (filed 7 days after the transaction; this appears outside the usual 2-business-day Form 4 reporting window).
• Transaction type/code: Award/Grant (A); price reported: $0.00.
• Shares involved: 11,887 RSUs granted and vested.
• Shares owned after transaction: Not specified in this filing.
• Footnote: The 11,887 shares represent restricted stock units granted as regular annual director compensation and vested immediately at grant (per footnote F1).
• No 10b5-1 plan, tax withholding, or cashless sale noted in this filing.

Context

• This is a routine director compensation award rather than an open-market purchase or sale. Such awards are common and do not necessarily signal the director’s view of the company’s near-term outlook. Immediate vesting means the RSUs became the director’s equity right away; any subsequent sale or withholding for taxes would be reported in future filings.